These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 27641336)
1. The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis. Li G; Li M; Hu J; Lei R; Xiong H; Ji H; Yin H; Wei Q; Hu G Oncogene; 2017 Feb; 36(7):989-998. PubMed ID: 27641336 [TBL] [Abstract][Full Text] [Related]
2. MiR-422a regulates cellular metabolism and malignancy by targeting pyruvate dehydrogenase kinase 2 in gastric cancer. He Z; Li Z; Zhang X; Yin K; Wang W; Xu Z; Li B; Zhang L; Xu J; Sun G; Wang L; Li Q; Huang X; Zhang L; Zhang D; Xu H; Xu Z Cell Death Dis; 2018 May; 9(5):505. PubMed ID: 29725130 [TBL] [Abstract][Full Text] [Related]
3. Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer. Liu X; Li J; Huang Q; Jin M; Huang G Mol Med; 2024 Apr; 30(1):56. PubMed ID: 38671369 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-23a promotes colorectal cancer cell survival by targeting PDK4. Deng YH; Deng ZH; Hao H; Wu XL; Gao H; Tang SH; Tang H Exp Cell Res; 2018 Dec; 373(1-2):171-179. PubMed ID: 30342991 [TBL] [Abstract][Full Text] [Related]
5. lncRNA PCAT19 promotes the proliferation of laryngocarcinoma cells via modulation of the miR-182/PDK4 axis. Xu S; Guo J; Zhang W J Cell Biochem; 2019 Aug; 120(8):12810-12821. PubMed ID: 30868666 [TBL] [Abstract][Full Text] [Related]
6. Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS‑activated pancreatic cancer cells. Terado T; Kim CJ; Ushio A; Minami K; Tambe Y; Kageyama S; Kawauchi A; Tsunoda T; Shirasawa S; Tanaka H; Inoue H Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35894141 [TBL] [Abstract][Full Text] [Related]
7. miR-363-3p inhibits tumor growth by targeting PCNA in lung adenocarcinoma. Wang Y; Chen T; Huang H; Jiang Y; Yang L; Lin Z; He H; Liu T; Wu B; Chen J; Kamp DW; Liu G Oncotarget; 2017 Mar; 8(12):20133-20144. PubMed ID: 28423618 [TBL] [Abstract][Full Text] [Related]
8. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis. Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of PDK4 Increases Lipogenesis and Associates with Poor Prognosis in Hepatocellular Carcinoma. Yang C; Wang S; Ruan H; Li B; Cheng Z; He J; Zuo Q; Yu C; Wang H; Lv Y; Gu D; Jin G; Yao M; Qin W; Jin H J Cancer; 2019; 10(4):918-926. PubMed ID: 30854098 [TBL] [Abstract][Full Text] [Related]
11. MiR-5683 suppresses glycolysis and proliferation through targeting pyruvate dehydrogenase kinase 4 in gastric cancer. Miao Y; Li Q; Sun G; Wang L; Zhang D; Xu H; Xu Z Cancer Med; 2020 Oct; 9(19):7231-7243. PubMed ID: 32780563 [TBL] [Abstract][Full Text] [Related]
12. Transforming Growth Factor β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer. Zhang Y; Zhang Y; Geng L; Yi H; Huo W; Talmon G; Kim YC; Wang SM; Wang J J Biol Chem; 2016 Aug; 291(33):17405-16. PubMed ID: 27330076 [TBL] [Abstract][Full Text] [Related]
13. FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression. Gopal K; Saleme B; Al Batran R; Aburasayn H; Eshreif A; Ho KL; Ma WK; Almutairi M; Eaton F; Gandhi M; Park EA; Sutendra G; Ussher JR Am J Physiol Heart Circ Physiol; 2017 Sep; 313(3):H479-H490. PubMed ID: 28687587 [TBL] [Abstract][Full Text] [Related]
14. The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance. Woolbright BL; Choudhary D; Mikhalyuk A; Trammel C; Shanmugam S; Abbott E; Pilbeam CC; Taylor JA Mol Cancer Ther; 2018 Sep; 17(9):2004-2012. PubMed ID: 29907593 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-490 regulates lung cancer metastasis by targeting poly r(C)-binding protein 1. Li J; Feng Q; Wei X; Yu Y Tumour Biol; 2016 Nov; 37(11):15221-15228. PubMed ID: 27683057 [TBL] [Abstract][Full Text] [Related]
16. Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis. Tao T; Chen M; Jiang R; Guan H; Huang Y; Su H; Hu Q; Han X; Xiao J Oncol Rep; 2017 Mar; 37(3):1430-1436. PubMed ID: 28184935 [TBL] [Abstract][Full Text] [Related]
17. miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer. Xin M; Qiao Z; Li J; Liu J; Song S; Zhao X; Miao P; Tang T; Wang L; Liu W; Yang X; Dai K; Huang G Oncotarget; 2016 Jul; 7(28):44252-44265. PubMed ID: 27317765 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer. Tan Z; Zheng H; Liu X; Zhang W; Zhu J; Wu G; Cao L; Song J; Wu S; Song L; Li J Oncotarget; 2016 Apr; 7(17):24076-87. PubMed ID: 26992223 [TBL] [Abstract][Full Text] [Related]
19. PDK4 promotes tumorigenesis and cisplatin resistance in lung adenocarcinoma via transcriptional regulation of EPAS1. Yu S; Li Y; Ren H; Zhou H; Ning Q; Chen X; Hu T; Yang L Cancer Chemother Pharmacol; 2021 Feb; 87(2):207-215. PubMed ID: 33221963 [TBL] [Abstract][Full Text] [Related]
20. Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma. Kumamoto T; Seki N; Mataki H; Mizuno K; Kamikawaji K; Samukawa T; Koshizuka K; Goto Y; Inoue H Int J Oncol; 2016 Nov; 49(5):1870-1880. PubMed ID: 27633630 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]